Basic Principles in Oncology Course

Applications closed.

Chairs: A. Eniu, CH – R. Anghel, RO

ESO is proposing a comprehensive course for oncology trainees in Europe intended to bridge the gap in education between courses for students and ESO’s well-known Masterclasses. The course aims to provide orientation to the guiding principles of multidisciplinary oncological management and life as a modern oncologist.

Although some of the principles underlying oncology practice are similar to those in other branches of medicine, sub-specialisation has reduced the exposure of medical students and junior residents to oncological concepts and practice. New oncology trainees face a number of specific challenges. These include navigation of an extensive curriculum with no clear starting point, a rapidly evolving clinical landscape, and increasing clinical demands. During training, residents must also strategically plan their careers, manage any academic focus, and maintain a healthy work-life balance.

The course is divided into 2 parts:

• Part 1: participants will be asked to view pre-recorded lectures which were recorded during the 1st edition of the course in Ljubljana, Slovenia in 2022 and will be made available on the e-Eso website.
• Part 2: in-person event

In collaboration with the University of Medicine and Pharmacy "Carol Davila" Bucharest.

OFFICIAL LANGUAGE

The official language will be English. No translation will be available.

CME ACCREDITATION

Application for CME recognition will be submitted to the Accreditation Council of Oncology in Europe (ACOE). The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.

     ESCO - The ESO College

Being selected to take part in this ESO Course is one of the ESO activities that gives participants eligibility to enroll in ESCO - the College of the European School of Oncology.
It also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits.
Full and active participation in the Basic Principles in Oncology course earns participants 15 ESCO credits.
Visit www.ESCO.org for more information on how to join ESCO.

PARTICIPATION

Attendance is limited to 50 participants and admittance is by competitive application only. Priority will be given to applicants who have attended an ESO-ESMO course for medical students or the ESO-ESSO-ESTRO course for medical students.

Successful applicants are granted free registration.

Accommodation at the course venue for arrival on Friday 22 September and departure on Saturday 23 September will be provided to participants not residing in the Bucharest area.

ORGANISING SECRETARIAT

Mariachiara Deleo
European School of Oncology (ESO)
Via Filippo Turati 29
20121 – Milan
ph +39 335 1814541
e-mail: mdeleo@eso.net

Dolores Knupfer
European School of Oncology (ESO)
Via Vincenzo Vela, 6
6500 Bellinzona
ph +41 91 820 09 50
e-mail: dknupfer@eso.net

Applications closed.

Ideal candidate:

• 1-3 years oncology training

Interested candidates should apply online providing the following as PDF files:

• CV (template provided) with the list of publications (if the list of publication is not provided, it will be assumed that no articles have been published)
• Motivation letter
• Support letter from mentor or head of department
• Clinical case abstract (template provided)

Matti Aapro, Clinique de Genolier, Genolier Cancer Center, Genolier, CH
Claudia Allemani, London School of Hygiene and Tropical Medicine, Department of Non-Communicable Disease Epidemiology, London, UK
Rodica Anghel, Institute of Oncology "Prof. Dr. Al Trestioreanu", Bucharest, RO
Assma Ben Aissa, Geneva University Hospital, Oncology Dpt., Geneva, CH
Stefan Bielack, Klinikum Stuttgart - Olgahospital, Dept. of Pediatric Oncology, Hematology, Immunology Dpt., Stuttgart, DE
Snezana Bosnjak, Institute of Oncology and Radiology of Serbia, Supportive Oncology & Palliative Care Dpt., Belgrade, RS
Silvia Brotea-Mosoiu, Oncology Institute of Bucharest, Medical Oncology Dept., Bucharest, RO
Jasna But Hadžic, Faculty of Medicine - University of Ljubljana, Dept. of Oncology, Ljubljana, SI
Franco Cavalli, Foundation for the Institute of Oncology Research (IOR), Presidenza, Bellinzona, CH
Tanja Cufer, University of Ljubljana, Medical Faculty, Ljubljana, SI
Giuseppe Curigliano, European Institute of Oncology / University of Milan, New Drugs for Innovative Therapies Division, Milano, IT
Filippo De Braud, Milan, IT
Alexandru Eniu, Riviera-Chablais Hospital, Interdisciplinary Oncology Service, Rennaz, CH
Alexandru Eniu, Riviera-Chablais Hospital, Interdisciplinary Oncology Service, Rennaz, CH
Alexandru Eniu, Riviera-Chablais Hospital, Interdisciplinary Oncology Service, Rennaz, CH
Laurentia Nicoleta Gales, Institutul Oncologic „Prof. Dr. Alexandru Trestioreanu", Oncology Dept., Bucharest, RO
Douglas Hanahan, ISREC- Swiss Institute for Experimental Cancer, Dept. of Life Sciences, Lausanne, CH
Matteo Lambertini, Policlinico San Martino Hospital – University of Genoa, Medical Oncology Department, U.O.C. Clinica di Oncologia Medica, Genoa, IT
Erika Matos, Institute of Oncology Ljubljana, Dept. of Medical Oncology, Ljubljana, SI
Olivia Pagani, Riviera-Chablais Hospital, Interdisciplinary Oncology Service, Rennaz, CH
Giancarlo Pruneri, National Cancer Institute, IRCCS Foundation, Pathology Dpt., Milano, IT
Isabel T. Rubio, Clínica Universidad de Navarra, Breast Surgical Oncology Dpt., Madrid, ES
Florian Scotté, Institute Gustave Roussy, Medical Oncology and supportive care Dpt., Villejuif, FR
Bostjan Seruga, Institute of Oncology Ljubljana, Dept. of Medical Oncology, Ljubljana, SI
Petra Steyerova, General University Hospital Prague, Clinic of Radiology, Breast Cancer screening and diagnostic center, Prague 2, CZ
Primoz Strojan, Institute of Oncology, Dept.of Radiation Oncology, Ljubljana, SI
Ian Tannock, Toronto, CA
Luzia Travado, Champalimaud Foundation, Champalimaud Clinical and Research Center, Lisbon, PT